1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-
- CAS No.
- 2367004-54-2
- Chemical Name:
- 1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-
- Synonyms
- XL-092;JUN04542;Zanzalintinib;Zanzalintinib (XL-092);N-(4-Fluorophenyl)-N-(4-((7-methoxy-6-(methylcarbamoyl)quinolin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide;1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-;Axl,c-Met/HGFR,Vascular endothelial growth factor receptor,p-MET,XL092,TAM Receptor,p-VEGFR2,Mer,ATP,XL 092,VEGFR,Inhibitor,Tyro3,XL-092,orally,inhibit
- CBNumber:
- CB98845693
- Molecular Formula:
- C29H25FN4O5
- Molecular Weight:
- 528.53
- MOL File:
- 2367004-54-2.mol
- Modify Date:
- 2024/7/2 8:55:42
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- Properties
Boiling point | 840.4±65.0 °C(Predicted) |
---|---|
Density | 1.408±0.06 g/cm3(Predicted) |
storage temp. | 4°C, protect from light |
solubility | DMSO : 25 mg/mL (47.30 mM; Need ultrasonic) |
pka | 13.14±0.46(Predicted) |
form | Solid |
color | Off-white to light brown |
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- Preparation Products And Raw materials
Raw materials
Preparation Products
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- Suppliers
Global( 29)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | China | 32760 | 60 | Inquiry |
InvivoChem | +1-708-310-1919 +1-13798911105 | United States | 6393 | 58 | Inquiry |
TargetMol Chemicals Inc. | +1-781-999-5354 | United States | 19973 | 58 | Inquiry |
Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 | China | 4694 | 58 | Inquiry |
Bide Pharmatech Ltd. | 400-1647117 15221909166 | China | 63720 | 58 | Inquiry |
Suzhou Haiben Pharmaceutical Co., Ltd | 14760821013 14760821013 | China | 5867 | 58 | Inquiry |
xinguokeji | 13120711461 | China | 446 | 58 | Inquiry |
Shanghai SuperLan Chemcial Technique Centre | 021-2022843681 15618226720 | China | 8931 | 58 | Inquiry |
Guangzhou Younan Technology Co., Ltd | 020-020-82000279 18988968278 | China | 4325 | 58 | Inquiry |
Olix (Shanghai) Pharmaceutical Technology Co., Ltd | 17316404525 | China | 9652 | 58 | Inquiry |
2367004-54-2(1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-)Related Search:
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-
XL-092
JUN04542
Zanzalintinib
Axl,c-Met/HGFR,Vascular endothelial growth factor receptor,p-MET,XL092,TAM Receptor,p-VEGFR2,Mer,ATP,XL 092,VEGFR,Inhibitor,Tyro3,XL-092,orally,inhibit
N-(4-Fluorophenyl)-N-(4-((7-methoxy-6-(methylcarbamoyl)quinolin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide
Zanzalintinib (XL-092)
2367004-54-2